Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
D000438:Alcohols / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D000831:Animals, Newborn; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism; D001921:Brain / Q000473:pathology; D002247:Carbon Isotopes; D002540:Cerebral Cortex / Q000187:drug effects* / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology* / Q000633:toxicity; D006325:Heart Atria / Q000187:drug effects* / Q000378:metabolism; D006651:Histocytochemistry; D006834:Hydrazines / Q000494:pharmacology; D007498:Iris / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008680:Metaraminol / Q000378:metabolism; D008750:Methyldopa / Q000494:pharmacology; D051379:Mice; D008856:Microscopy, Fluorescence; D009474:Neurons / Q000187:drug effects*; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D011984:Sensory Receptor Cells; D012701:Serotonin / Q000378:metabolism; D014316:Tritium
D000438:Alcohols; D002247:Carbon Isotopes; D006834:Hydrazines; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D014316:Tritium; D012701:Serotonin; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D008680:Metaraminol; D009526:Nialamide; D009638:Norepinephrine